MarkNtel Advisors recently published a detailed industry analysis of the Digital Therapeutics Market. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.
Insights and Analysis of the Digital Therapeutics Market (2024-2030)
The Global Digital Therapeutics Market is estimated to grow at a CAGR of around 20% during the forecast period, i.e., 2024-30.
Access the detailed PDF Sample report – https://www.marknteladvisors.com/query/request-sample/digital-therapeutics-market.html
What is driving the Digital Therapeutics Market?
Increasing Prevalence of Preventable Chronic Diseases to Infuse the Market Growth – There has been a significant prevalence of preventable chronic diseases, such as diabetes, cardiovascular diseases (CVDs), etc., across the globe. For instance, as per the International Diabetes Federation (IDF), worldwide, approximately 537 million adults aged between 20-79 years were living with diabetes in 2021. Further, the total number of patients with diabetes is projected to rise to 643 million by 2030 & 783 million by 2045.
Digital therapeutics assist patients to effectively manage diabetes by offering personalized management strategies, including blood glucose tracking & medication reminders. As a result, the demand for diabetes-based digital therapeutics, such as BlueStar by WellDoc, Livongo Diabetes Program, etc. has increased. This has further propelled the overall Digital Therapeutics Market.
What segments define the Digital Therapeutics Market from 2024 to 2030? How do these segments contribute to market dynamics and growth?
By Product
(Software, Hardware),
By Application
(Preventive, Treatment),
By Business Model
(Business-to-Consumer [B2C], Business-to-Business [B2B])
By Regions
North America, South America, Europe, Asia-Pacific, Middle East & Africa
Explore the Complete Digital Therapeutics Market Analysis Report – https://www.marknteladvisors.com/research-library/digital-therapeutics-market.html
Who are the leading key players shaping the Digital Therapeutics Market landscape?
Omada Health Inc., Google (Fitbit Health Solutions), 2Morrow® Inc., Teladoc Health. Inc. (Livongo), ResMed (Propeller Health), Aptar (Voluntis, Inc.), Welldoc, Inc., Canary Health, Noom, Inc., Biofourmis, Click Therapeutics, Better Therapeutics, Cognoa, CogniFit Inc., Virta Health, Others,
Questions Addressed in this Study
1.What factors are driving the Digital Therapeutics Market growth?
2.How is the Digital Therapeutics Market expected to grow over the next five years?
3.What are the key insights into the current trends in the Digital Therapeutics Market?
4.What is the current size of the Digital Therapeutics Market, and how is it projected to change in the future?
6.What is the future outlook for the Digital Therapeutics Market in terms of technological advancements and market expansion?
For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/digital-therapeutics-market.html
Why MarkNtel Advisors?
MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.
Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India